natgillin/translations-raw huggingface dataset:
Der findes ingen kliniske eller farmakokinetiske data fra patienter med svær leverdysfunktion (Child- Pugh score ≥10) (se pkt.
There are no clinical or pharmacokinetic data in patients with severe hepatic dysfunction (Child-Pugh score ≥ 10).
4. 2 og 4. 3).
(See sections 4.2 and 4.3.)
Farmakokinetikken i forbindelse med enkeltdosis etoricoxib 120 mg hos patienter med moderat til svær nyreinsufficiens og patienter med nyresygdom i terminalt stadie i hæmodialyse, var ikke signifikant forskellig fra den hos raske frivillige.
The pharmacokinetics of a single dose of etoricoxib 120 mg in patients with moderate to severe renal insufficiency and patients with end-stage renal disease on hemodialysis were not significantly different from those in healthy subjects.
50 ml/ min) (se pkt.
Hemodialysis contributed negligibly to elimination (dialysis clearance approximately 50 ml/ min).
4. 3 og 4. 4).
(See sections 4.3 and 4.4.)
Etoricoxibs farmakokinetik hos børn (< 12 år) er ikke undersøgt.
The pharmacokinetics of etoricoxib in paediatric patients (< 12 years old) have not been studied.
I en farmakokinetisk undersøgelse (n = 16) udført med unge (i aldersgruppen 12- 17 år), svarede farmakokinetikken hos unge med en vægt på 40- 60 kg, der fik etoricoxib 60 mg én gang daglig, og unge med en vægt > 60 kg, der fik etoricoxib 90 mg én gang daglig til farmakokinetikken hos voksne, der fik etoricoxib 90 mg, én gang daglig.
In a pharmacokinetic study (n=16) conducted in adolescents (aged 12 to 17) the pharmacokinetics in adolescents weighing 40 to 60 kg given etoricoxib 60 mg once daily and adolescents > 60 kg given etoricoxib 90 mg once daily were similar to the pharmacokinetics in adults given etoricoxib 90 mg once daily.
4. 2).
Safety and effectiveness of etoricoxib in paediatric patients have not been established (see section 4.2).
Rotter udviklede hepatocellulære og thyroide follikulære celleadenomer ved doser > 2 gange den daglige humandosis [90 mg] baseret på systemisk optagelse ved daglig dosering i ca.
Rats developed hepatocellular and thyroid follicular cell adenomas at > 2-times the daily human dose [90 mg] based on systemic exposure when dosed daily for approximately two years.
Hepatocellulære og thyroide follikulære celleadenomer set hos rotter anses for at være en artsspecifik konsekvens af hepatisk CYP- enzyminduktion hos rotter.
Hepatocellular and thyroid follicular cell adenomas observed in rats are considered to be a consequence of rat-specific mechanism related to hepatic CYP enzyme induction.
Etoricoxib er ikke vist at forårsage hepatisk CYP3A- enzyminduktion hos mennesker.
Etoricoxib has not been shown to cause hepatic CYP3A enzyme induction in humans.
I en 14 - ugers toxicitetsundersøgelse forårsagede etoricoxib gastrointestinale ulcera ved eksponering til højere doser end den, der sås hos mennesker i terapeutiske doser.
In the 14-week toxicity study etoricoxib caused gastrointestinal ulcers at exposures greater than those seen in man at the therapeutic dose.
I 53- ugers og 106- ugers toxicitetsundersøgelser sås også gastrointestinale ulcera ved eksponeringer sammenlignelige med doser til mennesker i terapeutiske doser.
In the 53- and 106-week toxicity study, gastrointestinal ulcers were also seen at exposures comparable to those seen in man at the therapeutic dose.
Etoricoxib var ikke teratogent i reproduktionstoksicitetsundersøgelser med rotter behandlet med 15 mg/ kg/ dag (dette repræsenterer ca.
Etoricoxib was not teratogenic in reproductive toxicity studies conducted in rats at 15 mg/ kg/ day (this represents approximately 1.5 times the daily human dose [90 mg] based on systemic exposure).
1, 5 gange den daglige humandosis [90 mg] baseret på systemisk optagelse).
In rabbits, a treatment related increase in cardiovascular malformations was observed at exposure levels below the clinical exposure at the daily human dose (90 mg).
Hos kaniner sås ingen behandlingsrelaterede eksterne eller skeletale føtale misdannelser.
However no treatment-related external or skeletal foetal
Sammenhængen med behandlingen er ikke påvist.
24 malformations were observed.
4. 3 og 4. 6).
In rats and rabbits, there was a dose dependent increase in post implantation loss at exposures greater than or equal to 1.5 times the human exposure (see sections 4.3 and 4.6).
2 gange større end plasmakoncentrationer.
Etoricoxib is excreted in the milk of lactating rats at concentrations approximately two-fold those in plasma.
Calciumhydrogenfosfat (vandfri) Croscarmellosenatrium Magnesiumstearat Mikrokrystallinsk cellulose
Calcium hydrogen phosphate (anhydrous) Croscarmellose sodium Magnesium stearate Microcrystalline cellulose
Carnaubavoks Lactosemonohydrat Hypromellose Titandioxid (E171) Glyceroltriacetat 30, 60 mg og 120 mg tabletten indeholder endvidere indigo carmine lake (E132) og gul jernoxid (E172).
Carnauba wax Lactose monohydrate Hypromellose Titanium dioxide (E171) Triacetin The 30-, 60- and 120-mg tablets also contain indigo carmine lake (E132) and yellow ferric oxide (E172).
30 mg Aluminium/ aluminiumblister i pakninger à 7 og 28 tabletter.
30 mg Aluminum/ aluminium blisters in packs containing 7 and 28 tablets.
60, 90 og 120 mg Aluminum/ aluminiumblister i pakninger à 2, 5, 7, 10, 14, 20, 28, 30, 50, 84, 98 eller 100 tabletter.
60, 90 and 120 mg Aluminum/ aluminium blisters in packs containing 2, 5, 7, 10, 14, 20, 28, 30, 50, 84, 98 or 100 tablets.
Aluminum/ aluminiumblister (enkeltdoser) i pakninger à 50 eller 100 tabletter.
Aluminum/ aluminium blisters (unit doses) in packs of 50 or 100 tablets.
Hvid, rund, HDPE- beholder med hvid polypropylenlukning indeholdende 30 tabletter og to 1- grams beholdere med tørremiddel eller 90 tabletter og en 1- grams beholder med tørremiddel.
White, round, HDPE bottles with a white, polypropylene closure containing 30 tablets and two1-gram desiccant containers or 90 tablets and one1-gram desiccant container.
Ingen særlige forholdsregler.
6.6 Special precautions for disposal 25 No special requirements.
[Se bilag I - Udfyldes nationalt]
MARKETING AUTHORISATION HOLDER
{Navn og adresse} < {tlf} > < {fax} > < {email} >
[See Annex 1- To be completed nationally.] {Name and address} {tel} {fax} {e-mail}
[Udfyldes nationalt]
[To be completed nationally.]
28 ETIKETTERING
26 LABELLING
ARCOXIA (se Bilag I) 30 mg filmovertrukne tabletter ARCOXIA (se Bilag I) 60 mg filmovertrukne tabletter ARCOXIA (se Bilag I) 90 mg filmovertrukne tabletter ARCOXIA (se Bilag I) 120 mg filmovertrukne tabletter
< ARCOXIA (see Annex 1) > 30 mg film-coated tablets< ARCOXIA (see Annex 1) > 60 mg film-coated tablets< ARCOXIA (see Annex 1) > 90 mg film-coated tablets < ARCOXIA (see Annex 1) > 120 mg film-coated tablets [See Annex I - To be completed nationally]
Etoricoxib
Etoricoxib
Lactose (se indlægssedlen for yderligere information).
Lactose (see leaflet for more information).
30 mg 7 filmovertrukne tabletter 28 filmovertrukne tabletter
30mg 7 Film-coated tablets 28 Film-coated tablets
60 mg - 90 mg - 120 mg 2 filmovertrukne tabletter 5 filmovertrukne tabletter 7 filmovertrukne tabletter 10 filmovertrukne tabletter 14 filmovertrukne tabletter 20 filmovertrukne tabletter 28 filmovertrukne tabletter 30 filmovertrukne tabletter 50 filmovertrukne tabletter 84 filmovertrukne tabletter 98 filmovertrukne tabletter 100 filmovertrukne tabletter 50 filmovertrukne tabletter (enkeltdosis) 100 filmovertrukne tabletter (enkeltdosis) 30 filmovertrukne tabletter (HDPE- flasker) 90 filmovertrukne tabletter (HDPE- flasker)
60 mg – 90 mg -120mg 2 Film coated tablets 5 Film-coated tablets 7 Film-coated tablets 10 Film-coated tablets 14 Film-coated tablets 20 Film-coated tablets 28 Film-coated tablets 30 Film-coated tablets 50 Film-coated tablets 84 Film-coated tablets 98 Film-coated tablets 100 Film-coated tablets 50 Film-coated tablets (unit dose) 100 Film-coated tablets (unit dose) 30 Film-coated tablets (HDPE bottles) 90 Film-coated tablets (HDPE bottles)
{Navn og adresse} < {tlf} > < {fax} > < {email} >
{Name and Address }< {tel }> < {fax }> < {e-mail }>
[Udfyldes nationalt]
GENERAL CLASSIFICATION FOR SUPPLY 29 [To be completed nationally]
31 15.
15.
32 MINDSTEKRAV TIL MÆRKNING PÅ BLISTERKORT ELLER BLISTERSTRIPS
30 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
[Se bilag I – Udfyldes nationalt]
[See Annex I - To be completed nationally]
33 MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER
31 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
HDPE- FLASKE
HDPE BOTTLE
ARCOXIA (se Bilag I) 60 mg filmovertrukne tabletter ARCOXIA (se Bilag I) 90 mg filmovertrukne tabletter ARCOXIA (se Bilag I) 120 mg filmovertrukne tabletter
< ARCOXIA (see Annex 1) > 60 mg film-coated tablets< ARCOXIA (see Annex 1) > 90 mg film-coated tablets< ARCOXIA (see Annex 1) > 120 mg film-coated tablets [See Annex I - To be completed nationally]
30 filmovertrukne tabletter (HDPE- flasker) 90 filmovertrukne tabletter (HDPE- flasker)
30 Film coated tablets (HDPE bottles) 90 Film coated tablets (HDPE bottles)
34 INDLÆGSSEDDEL
32 PACKAGE LEAFLET
ARCOXIA (se bilag I) 30 mg filmovertrukne tabletter ARCOXIA (se bilag I) 60 mg filmovertrukne tabletter ARCOXIA (se bilag I) 90 mg filmovertrukne tabletter ARCOXIA (se bilag I) 120 mg filmovertrukne tabletter
< ARCOXIA > 30 mg film-coated tablets< ARCOXIA > 60 mg film-coated tablets< ARCOXIA > 90 mg film-coated tablets < ARCOXIA > 120 mg film-coated tablets
Læs hele denne indlægsseddel grundigt, inden De begynder at tage medicinen. • Gem indlægssedlen.
Read all of this leaflet carefully before you start taking this medicine. • Keep this leaflet.
De kan få brug for at læse den igen. • Spørg lægen eller på apoteket, hvis der er mere, De vil vide. • Lægen har ordineret etoricoxib til Dem personligt.
You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you.
ARCOXIAs virkning og hvad De skal bruge det til 2.
What< ARCOXIA > is and what it is used for 2.
Det skal De vide, før De begynder at tage ARCOXIA 3.
Before you take< ARCOXIA > 3.
Sådan skal De tage ARCOXIA 4.
How to take< ARCOXIB > 4.
Sådan opbevarer De ARCOXIA 6.
How to store< ARCOXIA > 6.
ARCOXIAS VIRKNING OG HVAD DE SKAL BRUGE DET TIL
WHAT< ARCOXIA > IS AND WHAT IT IS USED FOR
• ARCOXIA tilhører en gruppe af lægemidler, der kaldes selektive COX- 2- hæmmere.
• < ARCOXIA > is one of a group of medicines called selective COX-2 inhibitors.
• ARCOXIA medvirker til at mindske smerte og hævelse (betændelse) i led og muskler hos personer, der har slidgigt, leddegigt, ankyloserende spondylitis (særlig form for leddegigt) og urinsyregigt.
These belong to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). • < ARCOXIA > helps to reduce the pain and swelling (inflammation) in the joints and muscles of people with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout.
Hvad er slidgigt?
What is osteoarthritis?
Hvad er leddegigt?
What is rheumatoid arthritis?
Leddegigt er en kronisk ledsygdom.
Rheumatoid arthritis is a long term inflammatory disease of the joints.
Den forårsager smerter, stivhed, hævelse og tiltagende tab af funktionen i de led, der er angrebet, samt betændelse i andre af kroppens organer.
It may also cause inflammation in other areas of the body.
Hvad er urinsyregigt?
What is gout?
DET SKAL DE VIDE, FØR DE BEGYNDER AT TAGE ARCOXIA
BEFORE YOU TAKE< ARCOXIA >
4) • hvis De har aktivt mavesår eller blødning i maven eller tarmene • hvis De har alvorlig leversygdom • hvis De har alvorlig nyresygdom • hvis De er eller kan være gravid, eller hvis De ammer (se "Graviditet og amning") • hvis De er under 16 år • hvis De har tarmbetændelse (såsom Crohns sygdom, colitis ulcerosa eller tyktarmsbetændelse) • hvis Deres læge har konstateret hjerteproblemer hos Dem, herunder nedsat hjertefunktion (moderat til svær), angina (brystsmerter), eller hvis De har haft et hjertetilfælde, har fået by- pass operation, har perifer arteriel sygdom (dårligt blodomløb i ben eller fødder på grund af snævre eller blokerede blodårer), eller anden form for slagtilfælde (herunder kortere varighed af mangel på blodtilførsel til hjernen, forbigående iskæmisk anfald).
Do not take< ARCOXIA >: • if you are allergic (hypersensitive) to etoricoxib or any of the other ingredients of < ARCOXIA > (see Further information, section 6) • if you are allergic to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors (see Possible Side Effects, section 4) • if you have a current stomach ulcer or bleeding in your stomach or intestines • if you have serious liver disease • if you have serious kidney disease • if you are or could be pregnant or are breast-feeding (see ‘Pregnancy and breast feeding’) • if you are under 16 years of age • if you have inflammatory bowel disease, such as Crohn’s Disease, Ulcerative Colitis, or Colitis • if your doctor has diagnosed heart problems including heart failure (moderate or severe types), angina (chest pain) or if you have had a heart attack, bypass surgery, peripheral arterial disease (poor circulation in legs or feet due to narrow or blocked arteries), or any kind of stroke (including mini- stroke, transient ischaemic attack or TIA).
Etoricoxib kan medføre let øget risiko for hjerte - og slagtilfælde, og derfor bør det ikke anvendes af dem, som tidligere har haft hjerteproblemer eller slagtilfælde • hvis De har forhøjet blodtryk, som ikke er velbehandlet (kontakt Deres læge eller sygeplejerske, hvis De ikke er sikker på, om Deres blodtryk er tilstrækkeligt behandlet).
Etoricoxib may slightly increase your risk of heart attack and stroke and this is why it should not be used in those who have already had heart problems or stroke • if you have high blood pressure that has not been controlled by treatment (check with your doctor or nurse if you are not sure whether your blood pressure is adequately controlled)
Vær ekstra forsigtig med at tage ARCOXIA ARCOXIA er måske ikke egnet for Dem, eller måske er det nødvendigt, at lægen følger Dem regelmæssigt, mens De tager medicinen, hvis noget af det følgende passer på Dem:
Take special care with< ARCOXIA > < ARCOXIA > may not be suitable for you, or you may need to be monitored regularly while taking it if any of the following apply to you:
ARCOXIA kan sløre eller skjule feber, som er tegn på infektion. • De er kvinde og forsøger at blive gravid. • De er ældre (dvs. over 65 år). • De har diabetes, forhøjet kolesterol eller er ryger.
• You have a history of stomach bleeding or ulcers. • You are dehydrated, for example by a prolonged bout of vomiting or diarrhoea. • You have swelling due to fluid retention. • You have a history of heart failure, heart attack or any other form of heart disease. • You have a history of stroke or mini stroke. • You have a history of high blood pressure .< ARCOXIA > can increase blood pressure in some people, especially in high doses, and your doctor will want to check your blood pressure from time to time. • You have any history of liver or kidney disease. • You are being treated for an infection. < ARCOXIA > can mask or hide a fever, which is a sign of infection. • You are a woman trying to become pregnant. • You are elderly (i.e., over 65 years of age). • You have diabetes, high cholesterol, or are a smoker.
Hvis De er i tvivl om, hvorvidt noget af ovenstående passer på Dem, skal De tale med lægen, før De tager ARCOXIA, for at finde ud af, om denne medicin er passende for Dem.
If you are not sure if any of the above apply to you, talk to your doctor before taking< ARCOXIA > to see if this medicine is suitable for you.
ARCOXIA virker lige godt hos ældre og yngre voksne patienter.
< ARCOXIA > works equally well in older and younger adult patients.
Hvis De er ældre (dvs. over 65 år), vil lægen undersøge Dem regelmæssigt.
If you are elderly (i. e., over 65 years of age), your doctor will want to appropriately keep a check on you.
Især hvis De tager et eller flere af følgende lægemidler, vil Deres læge følge Dem for at kontrollere, at Deres medicin virker, som den skal, efter at De er begyndt at tage ARCOXIA:
35 In particular if you are taking any of the following medicines, your doctor may want to monitor you to check that your medicines are working properly, once you start taking< ARCOXIA >:
Risikoen for mavesår er større, hvis De tager acetylsalicylsyre sammen med ARCOXIA.
• medicines that thin your blood (anticoagulants), such as warfarin • rifampicin (an antibiotic) • methotrexate (a drug used for suppressing the immune system, and often used in rheumatoid arthritis) • medicines used to help control high blood pressure and heart failure called ACE inhibitors and angiotensin receptor blockers, examples include enalapril and ramipril, and losartan and valsartan • lithium (a medicine used to treat some types of depression) • diuretics (water tablets) • ciclosporin or tacrolimus (drugs used for suppressing the immune system) • digoxin (a medicine for heart failure and irregular heart rhythm) • minoxidil (a drug used to treat high blood pressure) • salbutamol tablets or oral solution (a medicine for asthma) • birth control pills • hormone replacement therapy • aspirin, the risk of stomach ulcers is greater if you take< ARCOXIA > with aspirin. - < ARCOXIA > can be taken with low-dose aspirin.
Hvis De er i behandling med lavdosis acetylsalicylsyre til forebyggelse af hjerteanfald eller slagtilfælde, bør De ikke stoppe med medicinen uden at rådføre Dem med Deres læge.
If you are currently taking low-dose aspirin to prevent heart attacks or stroke, you should not stop taking aspirin until you talk to your doctor -do not take high dose aspirin or other anti-inflammatory medicines while taking< ARCOXIA >
Graviditet og amning ARCOXIA- tabletter må ikke tages under graviditet.
Pregnancy and breast-feeding< ARCOXIA > tablets must not be taken during pregnancy.
Hvis De er gravid, tror De kan være gravid eller planlægger at blive gravid, må De ikke tage tabletterne.
If you are pregnant or think you could be pregnant, or if you are planning to become pregnant, do not take the tablets.
Man ved ikke, om ARCOXIA udskilles i modermælk.
It is not known if< ARCOXIA > is excreted in human milk.
Hvis De ammer eller planlægger at amme, skal De rådføre Dem med Deres læge, før De tager ARCOXIA.
If you are breast-feeding, or planning to breast- feed, consult your doctor before taking< ARCOXIA >.
Hvis De tager ARCOXIA, bør De ikke amme.
If you are using< ARCOXIA >, you must not breast- feed.
Trafik - og arbejdssikkerhed Svimmelhed og søvnighed er rapporteret hos nogle patienter, der har taget ARCOXIA.
Driving and using machines Dizziness and sleepiness have been reported in some patients taking< ARCOXIA >.
Vigtig information om nogle af de øvrige indholdsstoffer i ARCOXIA ARCOXIA indeholder lactose.
Important information about some of the ingredients of< ARCOXIA > < ARCOXIA > contains lactose.
SÅDAN SKAL DE TAGE ARCOXIA
HOW TO TAKE< ARCOXIA >
Tag altid ARCOXIA nøjagtigt efter lægens anvisning.
Always take< ARCOXIA > exactly as your doctor has told you.
Børn og unge under 16 år bør ikke tage ARCOXIA.
< ARCOXIA > Tablets should not be taken by children or adolescents under 16 years of age.
ARCOXIA kan tages med eller uden mad.
Take< ARCOXIA > Tablets by mouth once a day. < ARCOXIA > can be taken with or without food.
38 Tag ikke mere end den anbefalede dosis til behandling af Deres tilstand.
Do not take more than the recommended dose for your condition.
Det er vigtigt, at De tager den mindste dosis, der kan lindre Deres smerter, og De bør ikke tage ARCOXIA i længere tid end nødvendigt.
It is important that you use the lowest dose that controls your pain and you should not take< ARCOXIA > for longer than necessary.
Slidgigt Den anbefalede dosis er 30 mg én gang dagligt, som kan øges til højst 60 mg én gang dagligt, hvis det er nødvendigt.
36 Osteoarthritis The recommended dose is 30 mg once a day, increase to a maximum of 60 mg once a day if needed.
Leddegigt Den anbefalede dosis er 90 mg én gang dagligt.
Rheumatoid arthritis The recommended dose is 90 mg once a day.
Urinsyregigt Den anbefalede dosis er 120 mg én gang dagligt, som kun bør tages i den akutte smertefulde periode, og behandlingen skal begrænses til maksimalt at vare i 8 dage.
Gout The recommended dose is 120 mg once a day which should only be used for the acute painful period, limited to a maximum of 8 days treatment.
Ankyloserende spondylitis Den anbefalede dosis er 90 mg én gang dagligt.
Ankylosing spondylitis The recommended dose is 90 mg once a day.
Patienter med leverproblemer • Hvis De har let nedsat leverfunktion, bør De højst tage 60 mg per dag. • Hvis De har moderat nedsat leverfunktion, bør De højst tage 60 mg hver anden dag eller 30 mg pr. dag.
People with liver problems • If you have mild liver disease, you should not take more than 60 mg a day. • If you have moderate liver disease, you should not take more than 60 mg every other day or 30 mg a day.
Hvis De har taget for meget ARCOXIA Tag aldrig flere tabletter end Deres læge anbefaler.
If you take more< ARCOXIA > than you should You should never take more tablets than the doctor recommends.
Hvis De tager for mange ARCOXIA- tabletter, skal De straks søge lægebehandling.
If you do take too many< ARCOXIA > tablets, you should seek medical attention immediately.
Hvis De har glemt at tage ARCOXIA Det er vigtigt, at De tager ARCOXIA, som lægen har foreskrevet.
If you forget to take< ARCOXIA > It is important to take< ARCOXIA > as your doctor has prescribed.
ARCOXIA kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
Like all medicines ,< ARCOXIA > can cause side effects, although not everybody gets them.
Hvis De får et eller flere af disse symptomer, skal De stoppe med at tage ARCOXIA og straks kontakte lægen: • kortåndethed, brystsmerter, hvis anklerne hæver, eller hvis nogle af disse symptomer bliver værre • gulfarvning af hud og øjne (gulsot) – dette er tegn på leversygdom • alvorlige eller hyppige mavesmerter eller afføringen bliver sort • allergisk reaktion – som kan medføre hudproblemer såsom sår eller blærer, eller hævelse af ansigt, læber, tunge eller svælg, som kan medføre besvær med at trække vejret.
If you develop any of these signs you should stop< ARCOXIA > and talk to your doctor immediately: • shortness of breath, chest pains, or ankle swelling appear or if they get worse • yellowing of the skin and eyes (jaundice) – these are signs of liver problems • severe or continual stomach pain or your stools become black • an allergic reaction- which can include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue, or throat which may cause difficulty in breathing
Følgende bivirkninger kan forekomme under behandling med ARCOXIA:
The following side effects can occur during treatment with< ARCOXIA >:
Almindelige (forekommer hos mere end 1 ud af 100 og hos færre end 1 ud af 10 patienter) Svaghedsfølelse og træthed, svimmelhed, hovedpine, influenza- lignende sygdom, diarré, tarmluft, kvalme, fordøjelsesbesvær (dyspepsi), mavesmerter eller ubehag i maven, halsbrand, ændringer i blodprøver vedrørende leveren, hævede ben og/ eller fødder på grund af væskeophobning (ødemer), forhøjet blodtryk, hjertebanken, blå mærker.
Common (occurring in greater than 1 out of 100 and less than 1 out of 10 people) Weakness and fatigue, dizziness, headache, flu-like illness, diarrhoea, wind, nausea, indigestion (dyspepsia), stomach pain or discomfort, heartburn, changes in blood tests related to your liver, swelling of the legs and/ or feet due to fluid retention (oedema), increased blood pressure, palpitations, bruising.